AG2R LA Mondiale Gestion D Actifs Purchases Shares of 10,938 Cardinal Health, Inc. $CAH

Key Points

• AG2R LA Mondiale Gestion D Actifs recently purchased 10,938 shares of Cardinal Health, Inc., valued at approximately $1.5 million, indicating growing institutional interest in the company.
• Cardinal Health reported Q1 earnings of $2.08 per share, exceeding analysts' expectations, though its revenue of $60.16 billion fell short of estimates.
• The company announced a quarterly dividend of $0.5107 per share, with a payment date set for October 15th, reflecting a commitment to shareholder returns.

AG2R LA Mondiale Gestion D Actifs bought a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,938 shares of the company's stock, valued at approximately $1,507,000.

Other large investors have also made changes to their positions in the company. Greykasell Wealth Strategies Inc. bought a new stake in shares of Cardinal Health in the 1st quarter worth about $26,000. Tompkins Financial Corp grew its holdings in shares of Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares during the last quarter. GW&K Investment Management LLC grew its holdings in shares of Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after purchasing an additional 144 shares during the last quarter. NBC Securities Inc. bought a new stake in shares of Cardinal Health in the 1st quarter worth about $48,000. Finally, Zions Bancorporation National Association UT bought a new stake in shares of Cardinal Health in the 1st quarter worth about $52,000. Institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

CAH has been the topic of several analyst reports. Morgan Stanley reaffirmed an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Bank of America upped their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Finally, Citigroup reiterated a "neutral" rating and set a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $165.93.

Cardinal Health Trading Down 0.1%

Cardinal Health stock opened at $152.34 on Friday. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44. The company has a market cap of $36.38 billion, a PE ratio of 23.62, a PEG ratio of 1.29 and a beta of 0.73. The company's 50-day moving average is $154.50 and its two-hundred day moving average is $147.79.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the prior year, the company posted $1.84 EPS. The company's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health's dividend payout ratio is presently 31.63%.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jason M. Hollar sold 107,705 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the transaction, the chief executive officer owned 235,901 shares in the company, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 271,676 shares of company stock worth $40,489,525. Insiders own 0.09% of the company's stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.